S. Nassir Ghaemi, MD, MPH.
Professor of Psychiatry and Director of the Psychopharmacology Consultation Clinic at Tufts Medical Center.
Dr. Ghaemi has no financial relationships with companies related to this material.
Avneet Soin, MD. Psychiatry resident, NYU Grossman School of Medicine. Deepti Anbarasan, MD. Associate Professor, Psychiatry & Neurology, New York University, New York.
Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report; Assistant Professor, NYU Langone Department of Psychiatry; practicing psychiatrist, Winston-Salem, NC.
Deepti Anbarasan, MD. Associate Professor, Psychiatry & Neurology, New York University, New York
Dr. Soin, Dr. Anbarasan, and Dr. Aiken have no financial relationships with companies related to this material.
Joshua Sonkiss, MD. Board-certified in adult, adolescent, and forensic psychiatry as well as addiction medicine.
Dr. Sonkiss has no financial relationships with companies related to this material.
Michael Posternak, MD. Psychiatrist in private practice, Boston, MA.
Dr. Posternak has no financial relationships with companies related to this material.
Sin Yan Lo, PMHNP-BC. Ms. Lo has no financial relationships with companies related to this material.
Kamron Fariba, DO. Dr. Fariba has no financial relationships with companies related to this material.
Michael Posternak, MD. Dr. Posternak has no financial relationships with companies related to this material.
Glen Spielmans, PhD. Dr. Spielmans has no financial relationships with companies related to this material.
Marilyn J. Vaché, MD. Dr. Vaché has no financial relationships with companies related to this material.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?t=1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
